Cargando…

HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells

The majority of breast cancers express estrogen receptor α (ERα), and most patients with ERα-positive breast cancer benefit from antiestrogen therapy. The ERα-modulator tamoxifen and ERα-downregulator fulvestrant are commonly employed antiestrogens. Antiestrogen resistance remains a clinical challen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alam, Muhammad Wasi, Persson, Camilla Ulrika, Reinbothe, Susann, Kazi, Julhash U., Rönnstrand, Lars, Wigerup, Caroline, Ditzel, Henrik Jorn, Lykkesfeldt, Anne E., Påhlman, Sven, Jögi, Annika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905469/ https://www.ncbi.nlm.nih.gov/pubmed/26849233 http://dx.doi.org/10.18632/oncotarget.7167

Ejemplares similares

Differential HIF-1α and HIF-2α Expression in Mammary Epithelial Cells during Fat Pad Invasion, Lactation, and Involution
por: Påhlman, Sven, et al.
Publicado: (2015)

Src-Like Adaptor Protein (SLAP) Binds to the Receptor Tyrosine Kinase Flt3 and Modulates Receptor Stability and Downstream Signaling
por: Kazi, Julhash U., et al.
Publicado: (2012)

The Src family kinase LCK cooperates with oncogenic FLT3/ITD in cellular transformation
por: Marhäll, Alissa, et al.
Publicado: (2017)

FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia
por: Chougule, Rohit A., et al.
Publicado: (2016)

SRC-like adaptor protein 2 (SLAP2) is a negative regulator of KIT-D816V-mediated oncogenic transformation
por: Rupar, Kaja, et al.
Publicado: (2018)

Understanding the Role of Activation Loop Mutants in Drug Efficacy for FLT3-ITD
por: Kazi, Julhash U., et al.
Publicado: (2023)

Activation of the Her2/neu receptor leads to antiestrogen resistance, but acquired resistance is not caused by altered ErbB expression and activation
por: Larsen, SS, et al.
Publicado: (2000)

The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
por: Moharram, Sausan A., et al.
Publicado: (2019)

Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
por: Moharram, Sausan A., et al.
Publicado: (2019)

The pitfall of the transient, inconsistent anticancer capacity of antiestrogens and the mechanism of apparent antiestrogen resistance
por: Suba, Zsuzsanna
Publicado: (2015)

Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum
por: Persson, Camilla U., et al.
Publicado: (2017)

Expression of GADS enhances FLT3-induced mitogenic signaling
por: Chougule, Rohit A., et al.
Publicado: (2016)

Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance
por: Emdal, Kristina B., et al.
Publicado: (2022)

A Receptor Tyrosine Kinase Inhibitor Sensitivity Prediction Model Identifies AXL Dependency in Leukemia
por: Nasimian, Ahmad, et al.
Publicado: (2023)

Src Drives Growth of Antiestrogen Resistant Breast Cancer Cell Lines and Is a Marker for Reduced Benefit of Tamoxifen Treatment
por: Larsen, Sarah L., et al.
Publicado: (2015)

Estrogenic or antiestrogenic therapies for multiple myeloma?
por: Sola, Brigitte, et al.
Publicado: (2007)

Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors
por: Jögi, Annika, et al.
Publicado: (2012)

Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer
por: Larsen, Sarah L, et al.
Publicado: (2015)

Src-like adaptor protein 2 (SLAP2) binds to and inhibits FLT3 signaling
por: Moharram, Sausan A., et al.
Publicado: (2016)

Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1
por: Påhlman, Lisa I, et al.
Publicado: (2015)

OR11-02 Structural Determinants of Pure Antiestrogenic Activity
por: Vallet, Amandine, et al.
Publicado: (2023)

Molecular Crosstalk Between MYC and HIF in Cancer
por: Li, Yanping, et al.
Publicado: (2020)

Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer
por: Jögi, Annika, et al.
Publicado: (2019)

Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells
por: Woo, Yu Mi, et al.
Publicado: (2015)

BEX1 acts as a tumor suppressor in acute myeloid leukemia
por: Lindblad, Oscar, et al.
Publicado: (2015)

Mechanisms of Anticancer Therapy Resistance: The Role of Cancer Stem Cells
por: Kazi, Julhash U.
Publicado: (2020)

Screening for estrogenic and antiestrogenic activities of plants growing in Egypt and Thailand
por: El-Halawany, Ali M., et al.
Publicado: (2011)

Antiestrogens: structure-activity relationships and use in breast cancer treatment
por: Traboulsi, T, et al.
Publicado: (2016)

Estrogenic/antiestrogenic activity of selected selective serotonin reuptake inhibitors
por: POP, ANCA, et al.
Publicado: (2015)

Exosome-Mediated Transfer of Cancer Cell Resistance to Antiestrogen Drugs
por: Semina, Svetlana E., et al.
Publicado: (2018)

Gingival cell growth with antiresorptive treatment combined with corticosteroids or antiestrogen
por: Ekholm, Heidi M., et al.
Publicado: (2021)

P479: TREATMENT IS SHAPING CLONAL EVOLUTION AND RESISTANCE PATTERNS IN MURINE KMT2A-REARRANGED LEUKEMIA WITH SUBCLONAL FLT3N676K
por: Falqués-Costa, Ton, et al.
Publicado: (2023)

NF‐κB and HIF crosstalk in immune responses
por: D'Ignazio, Laura, et al.
Publicado: (2015)

The crosstalk between HIFs and mitochondrial dysfunctions in cancer development
por: Bao, Xingting, et al.
Publicado: (2021)

Response of Estrogen Receptor-Positive Breast Cancer Tumorspheres to Antiestrogen Treatments
por: Ao, Ada, et al.
Publicado: (2011)

Combination of Antiestrogens and Omega-3 Fatty Acids for Breast Cancer Prevention
por: Manni, Andrea, et al.
Publicado: (2015)

Antiproliferative and Antiestrogenic Activities of Bonediol an Alkyl Catechol from Bonellia macrocarpa
por: Moo-Puc, Rosa, et al.
Publicado: (2015)

In This Issue: Antiestrogen Withdrawal, Yoga, and a Reflection on Quality of Clinical Trials
por: Block, Keith I.
Publicado: (2016)

Tyrosine 842 in the activation loop is required for full transformation by the oncogenic mutant FLT3-ITD
por: Kazi, Julhash U., et al.
Publicado: (2017)

Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling
por: Shah, Kinjal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uvnd7viogv5uhkjh0taigl6ptq